Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy

Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy

Pancreatic cancer is the most common lethal tumor in America. This lethality is related to limited treatment options. Conventional treatments involve the non-specific use of chemotherapeutical agents such as 5-FU, capecitabine, gemcitabine, paclitaxel, cisplatin, oxaliplatin, or irinotecan, which pr...

Full description

Bibliographic Details
Main Authors: Jorge A. Roacho-Pérez, Elsa N. Garza-Treviño, Paulina Delgado-Gonzalez, Zuca G-Buentello, Juan Luis Delgado-Gallegos, Christian Chapa-Gonzalez, Margarita Sánchez-Domínguez, Celia N. Sánchez-Domínguez, Jose Francisco Islas
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Life
Subjects:
pancreatic cancer
molecular markers
target therapy
nanomedicine
Online Access:https://www.mdpi.com/2075-1729/11/11/1187

Internet

https://www.mdpi.com/2075-1729/11/11/1187

Similar Items